Showing results 4 to 6 of 6
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
A Phase II study of dasatinib in patients with chemo-sensitive relapsed small cell lung cancer (SCLC): CALGB 30602 Proceeding/Conference:Journal of Thoracic Oncology | 2009 | ||
2017 | |||
2011 |